Citations

Mayo Clinic

Showing 10 of 108585 citations.

Comparison of Blood-Based Shotgun and Targeted Metagenomic Sequencing for Microbiological Diagnosis of Infective Endocarditis
Flurin, Laure , Fisher, Cody R. , Pritt, Bobbi S. , DeSimone, Daniel C. , Patel, Robin , Wolf, Matthew J, Pritt, Bobbi S , DeSimone, Daniel C , Patel, Robin , Fisher, Cody , Wolf, Matthew J

Open Forum Infectious Diseases | November 5, 2023 | Volume: 10 | Issue: 12 | Pages: No page available

10.1093/ofid/ofad546 | PMID 38075017 Get It

Abstract Background Shotgun and targeted metagenomic sequencing have been shown in separate studies to be potentially useful for culture-free pathogen identification in blood and/or plasma of patients with infective endocarditis (IE). However, the 2 approaches have not been directly compared. The aim of this study was to compare shotgun metagenomic sequencing with targeted metagenomic sequencing (tMGS) for organism identification in blood or plasma of patients with IE. Methods Patients with possible or definite IE were prospectively enrolled from October 2020 to July 2021. Shotgun metagenomic sequencing was performed with the Karius test, which uses microbial cell-free DNA (mcfDNA) sequencing to detect, identify, and quantitate DNA-based pathogens in plasma. tMGS was performed using a 16S ribosomal RNA (rRNA) polymerase chain reaction assay targeting the V1 to V3 regions of the 16S rRNA gene. Results were compared using the McNemar test of paired proportions. Results Samples from 34 patients were investigated. The Karius test was positive in 24/34 (71%), including 3/6 (50%) with blood culture–negative endocarditis (BCNE), which was not significantly different from the positivity rate of tMGS (P = .41). Results of the Karius test were concordant with tMGS in 75% of cases. The Karius test detected 2 cases of methicillin-resistant Staphylococcus aureus among the 7 S. aureus detections, in accordance with results of phenotypic susceptibility testing. The combination of blood cultures, the Karius test, and tMGS found a potential causative pathogen in 33/34 (97%), including 5/6 with BCNE. Conclusions The Karius test and tMGS yielded comparable detection rates; however, beyond organism identification, the Karius test generated potentially useful antibiotic resistance data.
Diet’s Impact on Post-Traumatic Brain Injury Depression: Exploring Neurodegeneration, Chronic Blood–Brain Barrier Destruction, and Glutamate Neurotoxicity Mechanisms
Boyko, Matthew , Gruenbaum, Benjamin F. , Merzlikin, Igor , Gruenbaum, Benjamin Fredrick , Boyko, Matthew , Oleshko, Anna, Zlotnik, Alexander Anatolievich

Nutrients | November 4, 2023 | Volume: 15 | Issue: 21 | Pages: 4681

10.3390/nu15214681 | PMID 37960334 Get It

Traumatic brain injury (TBI) has a profound impact on cognitive and mental functioning, leading to lifelong impairment and significantly diminishing the quality of life for affected individuals. A healthy blood–brain barrier (BBB) plays a crucial role in guarding the brain against elevated levels of blood glutamate, making its permeability a vital aspect of glutamate regulation within the brain. Studies have shown the efficacy of reducing excess glutamate in the brain as a treatment for post-TBI depression, anxiety, and aggression. The purpose of this article is to evaluate the involvement of dietary glutamate in the development of depression after TBI. We performed a literature search to examine the effects of diets abundant in glutamate, which are common in Asian populations, when compared to diets low in glutamate, which are prevalent in Europe and America. We specifically explored these effects in the context of chronic BBB damage after TBI, which may initiate neurodegeneration and subsequently have an impact on depression through the mechanism of chronic glutamate neurotoxicity. A glutamate-rich diet leads to increased blood glutamate levels when contrasted with a glutamate-poor diet. Within the context of chronic BBB disruption, elevated blood glutamate levels translate to heightened brain glutamate concentrations, thereby intensifying neurodegeneration due to glutamate neurotoxicity.
Modernizing Federal Oversight of Laboratory-Developed Tests — Toward Safety, Validity, and Utility
Singhal, Udit , Horrow, Caroline , Morgan, Todd M. , Kesselheim, Aaron S, Morgan, Todd M , Singhal, Udit , Kesselheim, Aaron Seth

New England Journal of Medicine | November 4, 2023 | Volume: 389 | Issue: 19 | Pages: 1735-1737

10.1056/nejmp2307585 | PMID 37929827 Get It

Endoscopic diagnosis and prevalence of early gastric cancer in India: A prospective study
Mohapatra, Ashutosh, Mohapatra, Sonmoon , Mahawar, Shruti, Pani, Krushna Chandra, Mohapatra, Nachiketa, Ramchandani, Mohan , Reddy, D. Nageshwar , Goenka, Mahesh Kumar , Uedo, Noriya , Goenka, Mahesh K

DEN Open | November 4, 2023 | Volume: 4 | Issue: 1 | Pages: No page available

10.1002/deo2.309 | PMID 37927951 Get It

AbstractObjectivesAlthough countries like Japan and South Korea have implemented nationwide endoscopic screening programs, there is limited evidence on the effectiveness of endoscopy for diagnosing early gastric cancer (EGC) in developing countries such as India. In the present study, we aimed to determine the feasibility of endoscopic detection of EGC from India.MethodsThe data was prospectively collected for all patients ≥40 years who underwent a diagnostic upper endoscopy from April to September 2021. A single endoscopist who performed the endoscopic procedures completed 1‐month training in advanced endoscopy in Japan. Following the training, the endoscopist continued to engage in internet‐based discussions regarding his cases encountered. Prior to this training, the endoscopist had not detected any EGC cases during his 12‐year gastroenterology practice.ResultsA total of 1033 patients were included in the study, with males accounting for 65.4% and a mean age 52 years. The average procedural time was 7.13 ± 4.8 min. A total of 25 patients (2.4%) were found to have GC, including 6 patients (0.6%) with EGC. Two patients had synchronous EGC lesions. All EGC patients were males, with an average age of 66 years. All EGCs were detected in the distal stomach in the presence of Helicobacter pylori infection and severe atrophic gastritis.ConclusionOur findings showed that the endoscopic detection of EGC is feasible in India. Optimal training on endoscopic diagnosis of EGC can improve the detection of such lesion. Further studies are warranted to assess the optimization and implementation of an endoscopic screening program for EGC in India.
Virtual Delivery of Stress Management and Resiliency Training (SMART) During the COVID-19 Pandemic to Hematology/Oncology Fellows: A Pilot Study
Williams, Colt , Pachman, Deirdre R. , Dierkhising, Ross , Rhee, Laura, Leventakos, Konstantinos , Chesak, Sherry S.

Journal of Wellness | November 4, 2023 | Volume: 5 | Issue: 2 | Pages: No page available

10.55504/2578-9333.1203 Get It

Introduction: Medical trainees experience a high degree of stress that predisposes them to burnout. This pilot study tested a scalable approach to deliver a validated resilience program (Stress Management and Resiliency Training (SMART)) among Hematology/Oncology fellows at an academic medical center. Methods: This was a mixed-methods, prospective, single-arm clinical trial involving Hematology/Oncology fellows at Mayo Clinic in Rochester, MN, USA. Four one-hour training sessions were conducted virtually with 26 fellows. Stress, burnout, and emotional resilience were measured at baseline, three months, and six months post-intervention using the Perceived Stress Scale (PSS-10), Maslach Burnout Inventory (MBI-HSS), and Connor-Davidson Resilience Scale (CD-RISC2). Changes in mean scores were assessed using paired t-tests. Feasibility and acceptability data were obtained during a virtual focus group. Results: Statistically significant improvements in mean stress (p = 0.004) and professional achievement (p < 0.001) were seen at three months post-intervention. At six months post-intervention, mean stress (p < 0.001) and professional achievement (p = 0.032) continued to improve, while improvements in emotional exhaustion (p = 0.001) and depersonalization (p < 0.001) also became significant. Focus group participants found the program beneficial and reported improved stress and work performance as a result of participation. Conclusion: Virtual implementation of the SMART program is feasible and resulted in improvements in stress and burnout. Focus group participants found the training beneficial, reporting lower stress and improved work performance.
Anterior clinoid meningiomas: surgical results and proposed scoring system to predict visual outcomes
Cohen-Cohen, Salomón , Graffeo, Christopher S. , Perry, Avital , Tooley, Andrea A. , Link, Michael J. , Botello-Hernández, Edgar , Carlstrom, Lucas P.

Journal of Neurosurgery | November 4, 2023 | Volume: 140 | Issue: 5 | Pages: 1295-1304

10.3171/2023.8.jns23894 | PMID 37922544 Get It

OBJECTIVE The authors report a single-surgeon experience with anterior clinoid meningiomas (ACMs) and propose a novel scoring system to predict visual outcomes based on preoperative risk factors. METHODS A cohort study of all ACMs that were surgically treated by a single surgeon between 2003 and 2021 was performed. Visual function was assessed by an ophthalmologist pre- and postoperatively. Based on the combination of visual fields and visual acuity, 4 visual grades were described. Favorable visual outcomes were defined as mild visual deficit or intact vision postoperatively. Unfavorable visual outcomes were defined as a severe or moderate visual deficit. Predictors of unfavorable visual outcomes were identified using multivariable logistic regression analysis. A scoring system was then created using the resulting β coefficient. A receiver operating characteristic curve analysis was performed to identify a cutoff point on the grading score for stratifying patients at risk for unfavorable visual outcomes. RESULTS Fifty-two patients met all inclusion criteria. Twenty-five (48%) patients presented with intact vision, and 27 (51%) presented with some visual dysfunction. Postoperative favorable visual outcomes were achieved in 39 patients (75%). Among the 27 patients presenting with visual dysfunction, 14 (52%) experienced improvement after surgery. No new visual deficits were observed among the 25 patients with intact vision at baseline. Nine patients (17%) had a reversible complication. Multivariable analysis showed that severe preoperative visual deficit (OR 13.03, 95% CI 2.64–64.39; p = 0.002), radiographic evidence of optic nerve (ON) encasement (OR 4.20, 95% CI 1.06–16.61; p = 0.04), intraoperative evidence of ON invasion (OR 17.31, 95% CI 2.91–102.86; p = 0.002), an average ganglion cell layer thickness of ≤ 70 µm (OR 21.54, 95% CI 2.94–159.04; p = 0.003), and an average retinal nerve fiber layer thickness of ≤ 80 µm (OR 13.68, 95% CI 1.91–98.00; p = 0.009) were associated with unfavorable visual outcome. The predictive score included the following factors: abnormal optical coherence tomography (OCT) findings, radiographic evidence of ON encasement by the tumor, and severe preoperative visual deficit. A score ≥ 4 of 6 points was demonstrated to be the cutoff associated with unfavorable visual outcome, with a sensitivity of 80%, specificity of 88%, positive predictive value of 80%, negative predictive value of 88%, and area under the curve of 0.847 (95% CI 0.674–1.0; p = 0.003). CONCLUSIONS The authors have designed a practical and novel scoring system to predict visual outcomes in patients with ACMs. This scoring system may guide preoperative discussions with patients and timely surgical intervention to yield optimal visual function outcomes. Although most patients have excellent neurosurgical outcomes, severe baseline visual deficits, ON encasement, and characteristic OCT abnormalities are associated with unfavorable visual function after ACM resection.
Decoding breast cancer Histopathology: Machine Learning-Enhanced Advanced Mathematical Models in Multi-B-Value MR Diffusion Imaging
Amini, Behnam, Ghasemi, Moein , Farazandeh, Dorreh, Farzaneh, Hana, Torabi, Sarah, Sedaghat, Mona, Jafarimehrabady, Niloofar, Hajiabbasi, Mobasher , Aziz, Ashkan, Gorjestani, OmidReza, Naviafar, Anahita, Alaei, Maryam , Karimi, Nastaran, Parsaei, Amirhossein , Doshmanziari, Reza, Vajihinejad, Maryam , Rikhtehgar, Masih , Nokiani, Alireza Almasi, Torabi, Sarah, Gorjestani, OmidReza, Hosseini, Mohammad M., Doshmanziari, Reza, Dehnavi, Ali Zare , Nokiani, Alireza Almasi

No container title available | November 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3520062/v1 Get It

Abstract This study aims to advance breast cancer (BC) subtype classification by employing machine learning algorithms to identify key diffusion parameters from apparent diffusion coefficient (ADC0-800) histogram, intravoxel incoherent motion (IVIM), and diffusion kurtosis imaging (DKI). A total of 148 newly diagnosed BC patients were enrolled, confirmed through core needle biopsy, and subjected to histopathological analyses to assess key molecular markers such as estrogen and progesterone receptors (collectively termed hormone receptors), HER2, and ki67. These markers were then used to classify BC subtypes. Utilizing advanced post-processing techniques on multi-b-value MR Images, the study employed a diverse set of machine learning (ML) algorithms (supervised, unsupervised, and deep learning techniques) to quantitatively assess their diagnostic utility and subsequently identify algorithmically refined diffusion signatures. Machine learning algorithms demonstrated varying efficacies in the classification of BC subtypes. Key diffusion parameters were prioritized based on feature importance values from the ML models with the highest mean AUC and were further validated using group comparison tests and univariate logistic regression. In conclusion, our findings underscore the importance of tailored ML algorithms in classifying BC subtypes and advocate for a synergistic approach in personalized oncology and precision medicine.
DLBCL: who is high risk and how should treatment be optimized?
Dąbrowska‐Iwanicka, Anna , Nowakowski, Grzegorz S.

Blood | November 3, 2023 | Volume: 144 | Issue: 25 | Pages: 2573-2582

10.1182/blood.2023020779 | PMID 37922443 Get It

Abstract Diffuse large B-cell lymphoma (DLBCL), not otherwise specified, is the most common subtype of large B-cell lymphoma, with differences in prognosis reflecting heterogeneity in the pathological, molecular, and clinical features. Current treatment standard is based on multiagent chemotherapy, including anthracycline and monoclonal anti-CD20 antibody, which leads to cure in 60% of patients. Recent years have brought new insights into lymphoma biology and have helped refine the risk groups. The results of these studies inspired the design of new clinical trials with targeted therapies and response-adapted strategies and allowed to identify groups of patients potentially benefiting from new agents. This review summarizes recent progress in identifying high-risk patients with DLBCL using clinical and biological prognostic factors assessed at diagnosis and during treatment in the front-line setting, as well as new treatment strategies with the application of targeted agents and immunotherapy, including response-adapted strategies.
Optimizing SH-SY5Y Cell Culture: Exploring the Beneficial Effects of an Alternative Media Supplement on Cell Proliferation and Viability
Santiago-Padilla, Valeria, Lim, Melina J., McLean, Pamela J. , McLean, Pamela J , Kaya, Zeynep Bengisu , Santiago-Padilla, Valeria, Boschen, Suelen L. , Atilla, Pergin

No container title available | November 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3495451/v1 Get It

Abstract In the quest to unravel the mysteries of neurological diseases, comprehending the underlying mechanisms is supreme. The SH-SY5Y human neuroblastoma cell line serves as a crucial tool in this endeavor; however, the cells are known for its sensitivity and slow proliferation rates. Typically, this cell line is cultured with 10% Fetal Bovine Serum (FBS) supplement. Nu-Serum (NuS), a low-protein alternative to FBS, is promising to advance cell culture practices. Herein, we evaluated the substitution of NuS for FBS to test the hypothesis that an alternative serum supplement can aid and promote SH-SY5Y cell proliferation and differentiation. Our findings revealed that the NuS-supplemented group exhibited a notable increase in adhered cells compared to both the FBS and serum-free (SF) groups. Importantly, cell viability remained high in both sera treated groups, with the NuS-supplemented cells displaying significantly larger cell sizes compared to the SF-treated group. Furthermore, cell proliferation rates were higher in the NuS-treated group, and neuroblast-like morphology was observed earlier than FBS group. Notably, both FBS and NuS supported the differentiation of these cells into mature neurons. Our data supports NuS as an alternative for SH-SY5Y cell culture, with the potential to elevate the quality of research in the neuroscience field.
Does Initiation of Prophylactic Antiseizure Medication Improve Neurological Outcomes in Patients With Acute Intracerebral Hemorrhage?
Crepeau, Amy Z. , Knox, Molly G., Sánchez, Cristina Valencia, Marks, Lisa , O’Carroll, Cumara B. , Freeman, William David, Valencia Sanchez, Cristina, O'Carroll, Cumara B., Marks, Lisa A , Chhabra, Nikita , Demaerschalk, Bart M. , Freeman, William D.

The Neurologist | November 3, 2023 | Volume: 28 | Issue: 6 | Pages: 422-425

10.1097/nrl.0000000000000537 | PMID 37922729 Get It

Objective: The objective of this study was to critically assess current evidence regarding the role of prophylactic antiseizure medication in patients presenting with acute intracerebral hemorrhage (ICH). Methods: The objective was addressed through the development of a structured critically appraised topic. This included a clinical scenario with a clinical question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom-line conclusions. Participants included resident neurologists, a medical librarian, and content experts in the fields of epilepsy, stroke neurology, neurohospitalist medicine, and neurocritical care. Results: A randomized clinical trial was selected for critical appraisal. The trial assessed whether prophylactic levetiracetam (LEV) use reduced the risk of acute seizures in patients with ICH, as defined by clinical or electrographic seizure, captured by continuous electroencephalogram 72 hours after enrollment. A total of 42 patients were included in the final analysis (19 in the LEV group and 23 in the placebo group). There was a significantly higher occurrence of seizures in the placebo versus LEV group (LEV 16% vs placebo 43%, P = 0.043). There were no differences in functional outcomes between the groups at 3, 6, or 12 months (P > 0.1). Conclusions: The role of prophylactic treatment with antiseizure medication in ICH remains unclear.